Dermatomyositis
📧 Sign up to get email alerts when something new happens for Dermatomyositis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-01-23Clinical Trial Update: Topical 10 % Nifedipine Versus 5% Sildenafil in Secondary Raynaud [EARLY_Phase 1]
The document notes completion of an early Phase 1 trial comparing topical 10% nifedipine with 5% sildenafil for secondary Raynaud's phenomen…
-
CLINICAL_TRIALS research · 2016-08-26Clinical Trial Update: Study of the Prevalence of Polymyositis and Dermatomyositis in Normandy
Completed observational study estimating the prevalence of polymyositis and dermatomyositis in the Normandy region.
-
CLINICAL_TRIALS research · 2016-07-01Clinical Trial Update: Pirfenidone in Progressive Interstitial Lung Disease Associated With Clinically Amyopathic Dermatomyositis [Phase 4]
Phase 4 clinical trial update evaluating pirfenidone for progressive interstitial lung disease associated with clinically amyopathic dermato…
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: Combined Treatment of Methotrexate + Glucocorticoids Versus Glucocorticoids Alone in Patients With PM and DM [Phase 3]
A Phase 3 trial comparing methotrexate plus glucocorticoids versus glucocorticoids alone in polymyositis and dermatomyositis; results from t…
-
CLINICAL_TRIALS research · 2015-11-06Clinical Trial Update: Dermatomyositis and Polymyositis Registry
A clinical trial registry entry for Dermatomyositis and Polymyositis sponsored by Phoenix Neurological Associates; the current status is unk…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders [Phase 1]
Completed Phase 1 pilot study evaluating total body irradiation with cyclophosphamide, anti-thymocyte globulin, and autologous CD34-selected…
-
CLINICAL_TRIALS trial_result · 2015-03-04Clinical Trial Update: Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM) [Phase 2]
Phase 2 trial evaluating rituximab for refractory adult and juvenile dermatomyositis and adult polymyositis; results have been posted.
-
CLINICAL_TRIALS trial_result · 2015-03-04Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Apremilast in the Treatment of Skin Disease in Patients With Dermatomyositis [NA]
A clinical trial evaluated the safety and efficacy of apremilast for skin involvement in dermatomyositis. The study was terminated and resul…
-
CLINICAL_TRIALS trial_result · 2014-11-05Clinical Trial Update: Efficacy and Safety Study of GB-0998 for Treatment of Steroid-resistant Polymyositis and Dermatomyositis (PM/DM) [Phase 3]
A Phase 3 trial assessing the efficacy and safety of GB-0998 for steroid-resistant polymyositis and dermatomyositis has completed.
-
CLINICAL_TRIALS research · 2013-08-01Clinical Trial Update: Understanding the Pathogenesis and Treatment of Childhood Onset Dermatomyositis [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial investigating the pathogenesis and treatment of childhood-onset dermatomyositis has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-03-19Clinical Trial Update: Outcome in Patients With Recent Onset Polymyositis and Dermatomyositis
This clinical trial update reports outcomes from a completed study evaluating patients with recent-onset polymyositis and dermatomyositis.
-
CLINICAL_TRIALS trial_result · 2012-05-28Clinical Trial Update: A Study to Evaluate Safety of Multi-Dose MEDI-545 in Adult Patients With Dermatomyositis or Polymyositis [Phase 1]
Phase 1 safety study of multi-dose MEDI-545 in adults with Dermatomyositis or Polymyositis has completed.
-
CLINICAL_TRIALS trial_result · 2012-02-16Clinical Trial Update: myoARRAY and TcLandscape Analysis for the Diagnosis of Inflammatory Myopathies [NA]
This update notes that a diagnostic clinical trial evaluating myoARRAY and TcLandscape for inflammatory myopathies has completed.
-
CLINICAL_TRIALS trial_result · 2011-06-21Clinical Trial Update: A Pilot Study of Etanercept in Dermatomyositis [Phase 1]
Phase 1 pilot trial evaluating etanercept for dermatomyositis was completed and results were posted. The study assessed safety and potential…
-
CLINICAL_TRIALS trial_result · 2010-07-19Clinical Trial Update: Anakinra in Myositis [Phase 2, Phase 3]
Karolinska Institutet-sponsored Phase 2 and Phase 3 trials evaluated anakinra for polymyositis and dermatomyositis (myositis), with inclusio…
-
CLINICAL_TRIALS trial_result · 2010-06-28Clinical Trial Update: Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases [Phase 4]
Phase 4 study assessing the safety and efficacy of an H1N1 vaccine in patients with rheumatic diseases. The current status of the trial is u…
-
CLINICAL_TRIALS trial_result · 2009-03-20Clinical Trial Update: Hand Function in Patients With Poly- or Dermatomyositis
Karolinska Institutet conducted a completed clinical trial assessing hand function in patients with polymyositis or dermatomyositis.
-
CLINICAL_TRIALS research · 2008-03-05Clinical Trial Update: Genetic and Family Studies of Inherited Muscle Diseases
NIAMS-sponsored clinical trial investigating genetic and familial factors in inherited muscle diseases has completed, involving conditions s…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Intravenousimmunoglobulin (IVIg) for the Treatment of Inflammatory Myopathies [Phase 2]
Phase 2 clinical trial evaluating intravenous immunoglobulin for inflammatory myopathies, including dermatomyositis, polymyositis, and inclu…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Methimazole to Treat Polymyositis and Dermatomyositis [Phase 2]
Phase 2 clinical trial evaluating methimazole for treatment of inflammatory myopathies (dermatomyositis and polymyositis) has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Safety and Effectiveness of h5G1.1-mAb for Dermatomyositis [Phase 2]
Phase 2 clinical trial evaluating the safety and effectiveness of h5G1.1-mAb for dermatomyositis; the study has completed.
-
FDA approval ·FDA Approves First Oral Drug Indicated to Treat Dermatomyositis in Adults
FDA approves Lisraya (brepocitinib) tablets as the first oral treatment indicated for dermatomyositis in adults.